| ESPEROVAX Esperovax, Inc.
98324183 20 Dec 2023 | on 07 Jan 2025 | Vaccines; Oral vaccines; Modified cells for medical or clinical use; y... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases Class 042 Class 042 Computer & Software Services & Scientific Services Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Research and development of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development | | | EGRESS RD Esperovax, Inc.
98324211 20 Dec 2023 | on 07 Jan 2025 | Vaccines; Oral vaccines; Modified cells for medical or clinical use; y... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases | | | HERCRNA Esperovax, Inc.
97450050 09 Jun 2022 | on 30 Jul 2024 | Vaccines; Modified cells for medical or clinical use; Pharmaceuticals ... Class 005 Class 005 Pharmaceutical Products Vaccines; Modified cells for medical or clinical use; Pharmaceuticals for the prevention or treatment of COVID19; Pharmaceuticals for the prevention or treatment of infection with respiratory syncytial virus (RSV); Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use; Medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing infection, disease, or disorders; Medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for treating infection, disease, or disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention of infection, disease, or disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of infection, disease, or disorders | | | VS TECHNOLOGY Esperovax, Inc.
88840107 19 Mar 2020 | on 26 Feb 2024 | Medical research in the field of vaccines and medicines; Research and ... Class 005 Class 005 Pharmaceutical Products "TECHNOLOGY" Class 042 Class 042 Computer & Software Services & Scientific Services Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Discovery, development and design of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development | | | ESPEROFLU Esperovax, Inc.
88784020 04 Feb 2020 | on 26 Feb 2024 | Vaccines; Oral vaccines; Modified cells for medical or clinical use; P... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use | | | ESPEROVAX Esperovax, Inc.
88780321 31 Jan 2020 | on 26 Feb 2024 | Medical research in the field of vaccines and medicines; Research and ... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use Class 042 Class 042 Computer & Software Services & Scientific Services Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Discovery, development and design of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development | | | EGRESS Esperovax, Inc.
88780364 31 Jan 2020 | on 26 Feb 2024 | Vaccines; Oral vaccines; Modified cells for medical or clinical use; P... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use | | | EGRESS RD Esperovax, Inc.
88780378 31 Jan 2020 | on 26 Feb 2024 | Vaccines; Oral vaccines; Modified cells for medical or clinical use; P... Class 005 Class 005 Pharmaceutical Products Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use | | | ESPEROMAX Esperovax, Inc.
90680240 29 Apr 2021 | on 30 Oct 2023 | Biological preparations for the treatment of disease; Biological prepa... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of disease; Biological preparations, namely, proteins, for the treatment of disease; Biological preparations, namely, antibodies, for the treatment of disease; Biological preparations, namely, hormones, for the treatment of disease; Biological preparations, namely, preparations for use in the treatment of cancer, inflammation, and/or infectious disease | | 
